A detailed history of Quest Partners LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Quest Partners LLC holds 1,997 shares of SAVA stock, worth $4,812. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,997
Previous 917 117.78%
Holding current value
$4,812
Previous $11.3 Million 418.96%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$9.57 - $35.08 $10,335 - $37,886
1,080 Added 117.78%
1,997 $58.8 Million
Q2 2024

Aug 06, 2024

SELL
$12.35 - $26.11 $5,026 - $10,626
-407 Reduced 30.74%
917 $11.3 Million
Q1 2024

May 09, 2024

SELL
$18.44 - $26.41 $72,395 - $103,685
-3,926 Reduced 74.78%
1,324 $26.9 Million
Q4 2023

Feb 09, 2024

BUY
$12.64 - $30.11 $66,360 - $158,077
5,250 New
5,250 $118 Million

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $96.6M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.